Skip to main content

BlackRock, Inc.

Position in BSX — Boston Scientific Corp

CIK 2012383 New York, NY

Position in BSX

as of Mar 31, 2026 · filed May 13, 2026
Position Value
$8,271,832,814
-$4,694,550,988 QoQ
Shares Held
131,822,037
-3.1% QoQ
Ownership
8.87%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2024
7 quarters on record
Voting authority Sole 89.62715998691479.ToString("F0")% Shared 0.ToString("F0")% None 10.372840013085218.ToString("F0")%

Common Shares in BSX Over Time

Shares Held

Position Value (USD)

Derivatives in BSX

reported options exposure · as of Jun 30, 2025
CallValue
$37,851,284
CallShares
352,400
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Medical Devices

Healthcare · as of Mar 31, 2026

BlackRock, Inc. holds $66,751,055,724 across 111 Medical Devices names. BSX ranks #4 (12.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 BSX
Boston Scientific Corp
This page
131,822,037 $8,271,832,814

All Filings in BSX

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $8,271,832,814 131,822,037
2025-12-31 $12,966,383,802 135,987,245
2025-09-30 $14,173,520,080 145,175,869
2025-06-30 $15,755,730,143 146,687,740
2025-06-30 $37,851,284 352,400
2025-03-31 $14,291,777,127 141,671,066
2024-12-31 $12,417,841,431 139,026,438
2024-09-30 $80,238,500 957,500
2024-09-30 $10,785,123,682 128,700,760